AUTHOREA
Log in Sign Up Browse Preprints

loading page

Impact of IFN- β1a in treatment of a COVID-19 Patient with Beta Thalassemia and Diabetes Mellitus: A Case Report
  • mohsen gholinataj jelodar,
  • samaneh mirzaei,
  • haniyeh dehghan
mohsen gholinataj jelodar
Shahid Sadoughi University of Medical Sciences and Health Services

Corresponding Author:[email protected]

Author Profile
samaneh mirzaei
Shahid Sadoughi University of Medical Sciences and Health Services
Author Profile
haniyeh dehghan
Shahid Sadoughi University of Medical Sciences and Health Services
Author Profile

Abstract

The present study aimed to report a case with COVID-19 with a history of chronic diseases, beta thalassemia intermedia, and DM. A 25-year-old man visited with covid 19 and treatment with IFN-β1a. According to the present report, the use of IFN-β1a was effective as a treatment option for COVID-19.

Peer review status:ACCEPTED

29 Jan 2022Submitted to Clinical Case Reports
Show details
Hide details
01 Feb 2022Submission Checks Completed
01 Feb 2022Assigned to Editor
10 Feb 2022Reviewer(s) Assigned
22 Jun 2022Review(s) Completed, Editorial Evaluation Pending
02 Jul 2022Editorial Decision: Accept